192 related articles for article (PubMed ID: 23761390)
1. Effects of escitalopram on attentional bias to cocaine-related stimuli and inhibitory control in cocaine-dependent subjects.
Liu S; Lane SD; Schmitz JM; Cunningham KA; John VP; Moeller FG
J Psychopharmacol; 2013 Sep; 27(9):801-7. PubMed ID: 23761390
[TBL] [Abstract][Full Text] [Related]
2. Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users.
Kalechstein AD; Mahoney JJ; Yoon JH; Bennett R; De la Garza R
Neuropharmacology; 2013 Jan; 64():472-8. PubMed ID: 22796108
[TBL] [Abstract][Full Text] [Related]
3. Relationship between attentional bias to cocaine-related stimuli and impulsivity in cocaine-dependent subjects.
Liu S; Lane SD; Schmitz JM; Waters AJ; Cunningham KA; Moeller FG
Am J Drug Alcohol Abuse; 2011 Mar; 37(2):117-22. PubMed ID: 21204739
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study.
Drueke B; Baetz J; Boecker M; Moeller O; Hiemke C; Gründer G; Gauggel S
Psychopharmacology (Berl); 2009 Dec; 207(2):213-23. PubMed ID: 19756527
[TBL] [Abstract][Full Text] [Related]
5. Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.
Passamonti L; Luijten M; Ziauddeen H; Coyle-Gilchrist ITS; Rittman T; Brain SAE; Regenthal R; Franken IHA; Sahakian BJ; Bullmore ET; Robbins TW; Ersche KD
Psychopharmacology (Berl); 2017 Aug; 234(15):2289-2297. PubMed ID: 28551713
[TBL] [Abstract][Full Text] [Related]
6. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.
Verrico CD; Haile CN; Mahoney JJ; Thompson-Lake DG; Newton TF; De La Garza R
Drug Alcohol Depend; 2014 Aug; 141():72-8. PubMed ID: 24928479
[TBL] [Abstract][Full Text] [Related]
7. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Wingen M; Kuypers KP; Ramaekers JG
Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
[TBL] [Abstract][Full Text] [Related]
8. Enhanced orbitofrontal cortex function and lack of attentional bias to cocaine cues in recreational stimulant users.
Smith DG; Simon Jones P; Bullmore ET; Robbins TW; Ersche KD
Biol Psychiatry; 2014 Jan; 75(2):124-31. PubMed ID: 23809860
[TBL] [Abstract][Full Text] [Related]
9. Alcohol Administration Increases Cocaine Craving But Not Cocaine Cue Attentional Bias.
Marks KR; Pike E; Stoops WW; Rush CR
Alcohol Clin Exp Res; 2015 Sep; 39(9):1823-31. PubMed ID: 26331880
[TBL] [Abstract][Full Text] [Related]
10. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.
Wingen M; Bothmer J; Langer S; Ramaekers JG
J Clin Psychiatry; 2005 Apr; 66(4):436-43. PubMed ID: 15816785
[TBL] [Abstract][Full Text] [Related]
11. Effects of alcohol preload on attentional bias towards cocaine-related cues.
Montgomery C; Field M; Atkinson AM; Cole JC; Goudie AJ; Sumnall HR
Psychopharmacology (Berl); 2010 Jun; 210(3):365-75. PubMed ID: 20352412
[TBL] [Abstract][Full Text] [Related]
12. Acute methylphenidate administration reduces cocaine-cue attentional bias.
Alcorn JL; Strickland JC; Lile JA; Stoops WW; Rush CR
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109974. PubMed ID: 32454161
[TBL] [Abstract][Full Text] [Related]
13. Anti-saccade error rates as a measure of attentional bias in cocaine dependent subjects.
Dias NR; Schmitz JM; Rathnayaka N; Red SD; Sereno AB; Moeller FG; Lane SD
Behav Brain Res; 2015 Oct; 292():493-9. PubMed ID: 26164486
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
[TBL] [Abstract][Full Text] [Related]
15. Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial.
Nuijten M; Blanken P; Van den Brink W; Goudriaan AE; Hendriks VM
J Psychopharmacol; 2016 Jul; 30(7):616-26. PubMed ID: 27147591
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
Stahl SM; Gergel I; Li D
J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
[TBL] [Abstract][Full Text] [Related]
17. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
Windischberger C; Lanzenberger R; Holik A; Spindelegger C; Stein P; Moser U; Gerstl F; Fink M; Moser E; Kasper S
Neuroimage; 2010 Jan; 49(2):1161-70. PubMed ID: 19833214
[TBL] [Abstract][Full Text] [Related]
18. A pilot investigation of acute inhibitory control training in cocaine users.
Alcorn JL; Pike E; Stoops WS; Lile JA; Rush CR
Drug Alcohol Depend; 2017 May; 174():145-149. PubMed ID: 28329718
[TBL] [Abstract][Full Text] [Related]
19. Treatment with escitalopram improves the attentional bias toward negative facial expressions in patients with major depressive disorders.
Zhou Z; Cao S; Li H; Li Y
J Clin Neurosci; 2015 Oct; 22(10):1609-13. PubMed ID: 26149404
[TBL] [Abstract][Full Text] [Related]
20. The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
Kellner M; Muhtz C; Demiralay C; Husemann J; Koelsch W; Yassouridis A; Wiedemann K
J Psychiatr Res; 2009 Mar; 43(6):642-8. PubMed ID: 18930474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
